Mapping the Uncharted Territories of Human Brain Malignancies

Cell. 2020 Jun 25;181(7):1454-1457. doi: 10.1016/j.cell.2020.06.003.

Abstract

Despite its success in multiple tumor types, immunotherapy remains poorly efficacious in brain malignancies. In this issue of Cell, Friebel et al. and Klemm et al. provide in-depth insights into the versatile nuances of immune cells in primary and metastatic brain tumors, granting the field with a rich framework to explore novel therapeutic avenues.

Publication types

  • Comment

MeSH terms

  • Brain Neoplasms* / therapy
  • Humans
  • Immunotherapy